MedKoo Cat#: 531377 | Name: PF-04671536
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PF-04671536 is a highly potent and selective inhibitor of phosphodiesterase 8B (PDE8B) phosphodiesterase 8A (PDE8A). In primary human pancreatic islets, PF-04671536 increases insulin secretion in a glucose-dependent manner.

Chemical Structure

PF-04671536
CAS#1305116-69-1

Theoretical Analysis

MedKoo Cat#: 531377

Name: PF-04671536

CAS#: 1305116-69-1

Chemical Formula: C14H18N8OS

Exact Mass: 346.1324

Molecular Weight: 346.41

Elemental Analysis: C, 48.54; H, 5.24; N, 32.35; O, 4.62; S, 9.25

Price and Availability

Size Price Availability Quantity
5mg USD 450.00
25mg USD 915.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
PF-04671536
IUPAC/Chemical Name
5-Methyl-3-[[(2R)-4 (2-thiazolylmethyl)-2-morpholinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-amine
InChi Key
QGTJGTFOISKMAD-SNVBAGLBSA-N
InChi Code
InChI=1S/C14H18N8OS/c1-9-17-13(15)12-14(18-9)22(20-19-12)7-10-6-21(3-4-23-10)8-11-16-2-5-24-11/h2,5,10H,3-4,6-8H2,1H3,(H2,15,17,18)/t10-/m1/s1
SMILES Code
NC1=C(N=NN2C[C@H]3CN(CC4=NC=CS4)CCO3)C2=NC(C)=N1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
PF-04671536 is a highly potent and selective inhibitor of phosphodiesterase 8B (PDE8B) phosphodiesterase 8A (PDE8A).
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 346.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
Foureau, A. V. I., Foureau, D. M., Farhangfar, C. J., & Mileham, K. F. (2023). Phosphodiesterase 8/9 inhibition to sensitize squamous non-small cell lung cancer (NSCLC) to pemetrexed (PMX): A double-edge strategy. Cancer Research, 83(7_Supplement), 281-281. Safitri, D., Harris, M., Potter, H., Yeung, H. Y., Winfield, I., Kopanitsa, L., ... & Ladds, G. (2020). Elevated intracellular cAMP concentration mediates growth suppression in glioma cells. Biochemical pharmacology, 174, 113823.